CSS LLC’s Revance Therapeutics, Inc. RVNC Stock Holding History

CSS LLC’s Portfolio RVNC Stock Details RVNC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-37,000	Closed	-$112K	–	1182
2024 Q4	$112K	Sell	37,000 -4,300	-10%	-$18.7K	0.01%	845
2024 Q3	$214K	Buy	+41,300	New	+$205K	0.01%	653

Other funds holding RVNC

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

CSS LLC's RVNC Position: Q1 2025 in Review

CSS LLC sold out of Revance Therapeutics, Inc. (RVNC) in Q1 2025, closing a stake of 79,519 shares — an estimated $242K sold.

CSS LLC first reported a position in RVNC in Q3 2024 and held it in 2 quarters. The position peaked at $328K in Q3 2024. 1 fund tracked by Wall St. Rank holds RVNC as of Q1 2025.

CSS LLC reported no remaining Revance Therapeutics, Inc. position as of Q1 2025 after selling out during the quarter.
CSS LLC sold 79,519 Revance Therapeutics, Inc. shares in Q1 2025, an estimated $242K.
CSS LLC first reported a position in Revance Therapeutics, Inc. in Q3 2024 and held it in 2 quarters.
CSS LLC's Revance Therapeutics, Inc. position peaked at $328K in Q3 2024.
1 fund tracked by Wall St. Rank held Revance Therapeutics, Inc. as of Q1 2025.

Based on CSS LLC's 13F filing for Q1 2025, filed 15 May 2025.